logo
Share SHARE
FONT-SIZE Plus   Neg

Sanofi Q1 Profit Rises; Backs 2012 Business EPS View - Quick Facts

Sanofi (SNY,SNYNF.PK) posted first quarter net income attributable to shareholders of 1.83 billion euros or 1.38 euros per share, up from 1.22 billion euros or 0.93 euros per share a year ago.

Business earnings per share for the quarter were 1.85 euros, 11.4% higher than the year ago quarter. Business EPS was up 7.2% at constant exchange rates.

Net sales reached 8.511 billion euros, up 9.4% on a reported basis from the prior-year quarter. At constant exchange rates, and adjusting for changes in the scope of consolidation, primarily the consolidation of Genzyme, net sales decreased 0.6%.

Commenting on the Group's performance in Q1 2012, Sanofi Chief Executive Officer, Christopher Viehbacher said,

"During the first quarter, our Business EPS grew by 7.2%. This strong performance was driven by Genzyme, our growth platforms, and cost savings. This quarter also reflects the production recovery of Genzyme with the first shipment of Fabrazyme® produced in Framingham in March.

In addition, we have submitted three new products to regulatory authorities, and released impressive clinical results for our anti-PCSK9 agent and for Lemtrada at recent medical congresses. Although as expected, Plavix will lose exclusivity in May in the U.S., the strong underlying performance of the business is consistent with our medium term growth outlook".

Taking into account the loss of Plavix and Avapro exclusivity in the U.S., the performance of growth platforms, contribution from Genzyme and cost control as well as other generic competition, 2012 business EPS is still targeted to be 12% to 15% lower at constant exchange rates than 2011, barring unforeseen adverse events.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The bench to bedside journey of drugs is fraught with challenges. It is estimated that only 5 in 5,000 compounds that enter preclinical testing make it to human testing, and out of those 5, only 1 may pass through all the regulatory hurdles needed to reach pharmacy shelves. Major League Baseball is talking expansion for the first time in a few decades. Owners stand to make a pretty penny from expansion fees and subsequent television rights. The possibility of a more balanced schedule is also enticing. Strong expansion candidates in the U.S. and Canada are ready... The New York Times is teaming up with Google again to give away Google Cardboard, the virtual reality headsets, but this time only to its "most loyal" digital subscribers. The company said that the digital-only subscribers selected for this distribution were chosen based on the duration of their subscriptions.
comments powered by Disqus
Follow RTT